Circadian Clocks in the Regulation of Neurotransmitter Systems.
Journal
Pharmacopsychiatry
ISSN: 1439-0795
Titre abrégé: Pharmacopsychiatry
Pays: Germany
ID NLM: 8402938
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
medline:
17
5
2023
pubmed:
31
10
2019
entrez:
31
10
2019
Statut:
ppublish
Résumé
To anticipate and adapt to daily recurring events defined by the earth's rotation such as light-dark and temperature cycles, most species have developed internal, so-called circadian clocks. These clocks are involved in the regulation of behaviors such as the sleep-wake cycle and the secretion of hormones and neurotransmitters. Disruptions of the circadian system affect cognitive functions and are associated with various diseases that are characterized by altered neurotransmitter signaling. In this review, we summarize the current knowledge about the interplay of the circadian clock and the regulation of psychiatric health and disease.
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108-117Informations de copyright
Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany.
Déclaration de conflit d'intérêts
Johannes Thome has received financial support from pharmaceutical companies (Actelion, Astra Zeneca, Bristol-Myers Squibb, EVER Neuro Pharma GmbH, Janssen-Cilag, Lilly, Lundbeck, MEDICE, Merz, Novartis, Pfizer, Roche, Servier, Shire, Trommsdorff) some of which manufacture medication used in the treatment of ADHD patients. Jana-Thabea Kiehn, Denise Palm, Frank Faltraco, and Henrik Oster have no potential conflicts of interest to disclose.